Detalhe da pesquisa
1.
Obesity: a perfect storm for carcinogenesis.
Cancer Metastasis Rev
; 41(3): 491-515, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038791
2.
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Br J Cancer
; 128(6): 958-966, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823364
3.
Window of opportunity clinical trial designs to study cancer metabolism.
Br J Cancer
; 122(1): 45-51, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819180
4.
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin.
Br J Cancer
; 122(2): 258-265, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819193
5.
New role of fat-free mass in cancer risk linked with genetic predisposition.
Sci Rep
; 14(1): 7270, 2024 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538606
6.
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Nat Commun
; 14(1): 4444, 2023 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488191
7.
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Cancer Cell
; 41(7): 1222-1241.e7, 2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433281
8.
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.
NPJ Breast Cancer
; 8(1): 45, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393425
9.
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Eur J Cancer
; 124: 131-141, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765988
10.
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Nat Commun
; 14(1): 4741, 2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550302
11.
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.
Cell Metab
; 28(5): 679-688.e4, 2018 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30244975
12.
Early phase cancer clinical trials: design, ethics and future directions.
Br J Hosp Med (Lond)
; 76(7): 409-13, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140560
13.
Neoadjuvant Window Studies of Metformin and Biomarker Development for Drugs Targeting Cancer Metabolism.
J Natl Cancer Inst Monogr
; 2015(51): 81-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063894
14.
Non-cancer medications for patients with incurable cancer: time to stop and think?
Br J Gen Pract
; 60(573): 243-4, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20353669